Skip to content

Combined inhibitory and excitatory theta-burst stimulation for post-stroke aphasia

Combined inhibitory and excitatory theta-burst stimulation for post-stroke aphasia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068086
Enrollment
Unknown
Registered
2023-02-07
Start date
2023-02-13
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke aphasia

Interventions

Experimental group:continuous theta-burst stimulation combined intermittent theta-burst stimulation
control group:sham continuous theta-burst stimulation combined sham intermittent theta-burst stimulation

Sponsors

China Rehabilitation Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In accordance With the Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke and Guidelines for the Management of Acute Ischemic Stroke Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association of diagnostic criteria for ischemic or hemorrhagic stroke, lesions in the left hemisphere, course of disease 2-8 weeks; 2. Meeting the diagnostic criteria for aphasia, WAB's aphasia quotient was less than 93.8; 3. First onset or with a history of stroke without apparent sequelae; 4. Age 35-75 years old; 5. Normal language function before onset, native Chinese, primary school education or above; 6. Patients and their families understand the trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Aphasia caused by brain tumor, Parkinson's syndrome, motor neurone disease and other neurological diseases or brain trauma; 2. There are metal foreign bodies or any implanted electronic equipment in the body, there are MRI scanning contraindications such as claustrophobia, and TMS treatment contraindications; 3. A history of epilepsy (at least 2 uninduced seizures with an interval of more than 24 hours, or seizures within the past 12 months); 4. Patients with severe heart, lung, liver, kidney and other systemic diseases that cannot be controlled by conventional drugs; 5. Patients with severe dysarthria, cognitive impairment, auditory and visual impairment, severe depression, anxiety, etc., who were unable to cooperate with the test; 6. A history of alcohol and drug abuse; 7. women who are pregnant or planning to become pregnant; 8. Patients who had received transcranial magnetic stimulation in the previous 3 months; 9. Participants in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Western Aphasia Battery;

Secondary

MeasureTime frame
BDAE classification of aphasia severity;Western Aphasia Battery;

Countries

China

Contacts

Public ContactJingdu Zhao

China Rehabilitation Research Center

zjdklsa008@163.com+86 136 9654 7715

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026